Oncotelic Therapeutics, Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2012
Total Assets: $5.4M
Liabilities Breakdown FY2012
Total Liabilities: $901.0K
Asset Breakdown
Total Assets: $5.4M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $4.9M | 90.8% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $13.0K | 0.2% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $191.0K | 3.5% |
| Other Assets | $297.0K | 5.5% |
Liabilities Breakdown
Total Liabilities: $901.0K
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $416.0K | 46.2% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $485.0K | 53.8% |